| An Indian drug company, criticized by activist groups opposed to the death penalty, has pledged to stop selling chemicals used for lethal injections to American correctional facilities.
Kayem was targeted by the London-based Reprieve, which fights the death penalty. A death row inmate in Nebraska has also filed a motion challenging the state’s use of Kayem’s drug, as it is not registered with the Food and Drug Administration. Correctional officials in U.S. states that administer the death penalty are reportedly facing difficulty in securing the drug, after its U.S. manufacturer halted production this year |
Post your comment